La gestion thérapeutique d’une cicatrice chéloïde après une dermite cortisonique (notice n° 126017)
[ vue normale ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 03612cam a2200385 4500500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250112014903.0 |
| 041 ## - LANGUAGE CODE | |
| Language code of text/sound track or separate title | fre |
| 042 ## - AUTHENTICATION CODE | |
| Authentication code | dc |
| 100 10 - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Chhiti, Sokaina |
| Relator term | author |
| 245 00 - TITLE STATEMENT | |
| Title | La gestion thérapeutique d’une cicatrice chéloïde après une dermite cortisonique |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Date of publication, distribution, etc. | 2023.<br/> |
| 500 ## - GENERAL NOTE | |
| General note | 90 |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc. | Keloids and hypertrophic scars occur in 30-90% of patients. The two entities have different clinical and histochemical characteristics and unfortunately still represent a great challenge for clinicians due to the lack of effective treatments. Current advances reveal new preventive and therapeutic options that offer hope for managing this widespread, chronic and debilitating problem. Case report: We report the efficacy of the combination of fractionated carbon dioxide (FCO2) laser and intra-lesional 5-fluorouracil (5-FU) for the treatment of a mid-thoracic keloid scar resistant to intra-lesional infiltration steroids and pressotherapy. Discussion: The appearance of cortisone dermatitis at the site of corticosteroid infiltration makes it necessary to seek an effective therapeutic alternative to minimize the risk of recurrence and resistance without hesitating to combine several therapeutic means such as laser, 5-FU or Bleomycin and cryosurgery… Conclusion: Effort is needed to choose the treatment with maximum results. Combination therapy appears to be an acceptable method for the treatment of keloids. |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc. | Les chéloïdes et les cicatrices hypertrophiques sont les plus fréquentes des cicatrices, dont elles présentent 30 à 90 %. Ces deux entités présentent des caractéristiques cliniques et histochimiques différentes et constituent malheureusement encore un grand défi pour les cliniciens en raison du manque de traitements efficaces. Les progrès actuels révèlent de nouvelles options préventives et thérapeutiques qui offrent un espoir de gérer ce problème répandu, chronique et débilitant. Rapport de cas : nous rapportons l’efficacité de la combinaison du laser à dioxyde de carbone fractionné (FCO2) et du 5-fluorouracile (5-FU) intralésionnel pour le traitement d’une cicatrice chéloïde médiothoracique résistante aux infiltrations intralésionnelles de stéroïdes et à la pressothérapie. Discussion : l’apparition d’une dermite cortisonique sur le site d’infiltration des corticoïdes impose de rechercher une alternative thérapeutique efficace pour minimiser le risque de récidive et de résistance sans hésiter à combiner plusieurs moyens thérapeutiques tels que le laser, le 5-FU ou la bléomycine et la cryochirurgie. Conclusion : un effort est nécessaire pour choisir le traitement avec le maximum de résultats. La thérapie combinée semble être une méthode acceptable pour le traitement des chéloïdes. |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | corticostéroïdes |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | chéloïde |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | 5-fluorouracile (5-FU) |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | cicatrice |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | bléomycine |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | laser |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | corticosteroids |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | 5-FU |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | scar. |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | bleomycin |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | keloid |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | laser |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Baybay, Hanane |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Hashas, Fatima Zahra |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Douhi, Zakia |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Soughi, Meryem |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Elloudi, Sara |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Mernissi, Fatima Zahra |
| Relator term | author |
| 786 0# - DATA SOURCE ENTRY | |
| Note | Cahiers Santé Médecine Thérapeutique | 32 | 5 | 2023-09-01 | p. 278-280 | 2780-8858 |
| 856 41 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://shs.cairn.info/revue-cahiers-sante-medecine-therapeutique-2023-5-page-278?lang=fr">https://shs.cairn.info/revue-cahiers-sante-medecine-therapeutique-2023-5-page-278?lang=fr</a> |
Pas d'exemplaire disponible.
Réseaux sociaux